Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

CPRXCPRX
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in CATALYST PHARMACEUTICALS INC

NORTHERN TRUST CORP holds 1.3M shares of CPRX (CATALYST PHARMACEUTICALS INC), worth $41.8M as of 2026-Q2. The position was increased (+7.5% shares). CPRX represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$41.8M

Current Shares

1.3M

Total Value Change

+$14.3M

Total Shares Change

-53,280

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.3M
+7.5%
$41.8M0.0%$31.43
31
2026-Q1
Increased
1.2M
+2.1%
$30.6M0.0%$23.92
29
2025-Q4
Decreased
1.2M
-4.1%
$28.3M0.0%$23.29
0
2025-Q3
Decreased
1.3M
-0.9%
$24.9M0.0%$19.55
0
2025-Q2
Decreased
1.3M
-14.2%
$27.7M0.0%$21.78
0
2025-Q1
Decreased
1.5M
-1.2%
$36M0.0%$24.69
0
2024-Q4
Increased
1.5M
+8.7%
$31.4M0.0%$21.07
31
2024-Q3
Decreased
1.4M
-0.2%
$27.5M0.0%$19.56
0

Other major holders of CPRX: BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used